Analysis of 24-month interim data from the pivotal CYPRESS clinical trial has shown spectacles that use SightGlass Vision Diffusion Optics Technology significantly reduce both
The eyes may signal neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) according to new research from Flinders
Just one month after it took to the road, a mobile vision bus established to address inequitable access to eye health in Aotearoa New
Macular Disease Foundation Australia has appointed Dr Kathy Chapman to the role of Chief Executive Officer. She commenced in the role on 18 July
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
